Total Funding
28
63
Total FundingPost-IPO Equity raised
Growth Score
-4 pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
234323
Olymvax is a pharmaceutical company involved in the research and development of human vaccines.
About the Company
Olymvax is a biopharmaceutical firm that develops, manufactures, and sells human vaccinations. They are integrating global resources, maintaining cooperation with all parties, and striving to develop technological innovation for the development of vaccines. Their products include the tetanus vaccine and the Haemophilus influenzae B vaccine.
